|
|
||||||||
Clinical Chemistry, Vol 35, 1416-1422, Copyright © 1989 by American Association for Clinical Chemistry
K Linnet
Department of Clinical Chemistry, University Hospital, Copenhagen, Denmark.
Design of control charts for the mean, the within-run component of variance, and the ratio of between-run to within-run components of variance is outlined. The between-run component of variation is the main source of imprecision for analytes determined by an enzymo- or radioimmunoassay principle; accordingly, explicit control of this component is especially relevant for these types of analytes. Power curves for typical situations are presented. I also show that a between- run component of variation puts an upper limit on the achievable power towards systematic errors. Therefore, when the between-run component of variation exceeds the within-run component, use of no more than about four controls per run is reasonable at a given concentration.
The following articles in journals at HighWire Press have cited this article:
![]() |
H. G. McCoy and K. R. Labrosse State of the Art: Measurement of Drug Concentrations for Therapeutic Drug Monitoring Journal of Pharmacy Practice, January 1, 1989; 2(6): 335 - 346. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |